• Login
    View Item 
    •   MMUST Institutional Repository
    • University Journals/ Articles
    • Gold Collection
    • View Item
    •   MMUST Institutional Repository
    • University Journals/ Articles
    • Gold Collection
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Discovery of α-amylase and α-glucosidase dual inhibitors from NPASS database for management of Type 2 Diabetes Mellitus: A chemoinformatic approach

    Thumbnail
    View/Open
    Second+Order+Extended+Ensemble+Filter+for+Non-linear+Filtering+-+Midenyo+et+al.+-+AJERNET.pdf (1.019Mb)
    Date
    2024-11-14
    Author
    Ndarawit, Wilberforce
    Ochieng, Charles Otieno
    Angwenyi, David
    Cru, Jorddy N.
    Santos, Cleydson B. R.
    Kimani, Njogu M.
    Metadata
    Show full item record
    Abstract
    Postprandial hyperglycemia, typical manifestation of Type 2 Diabetes Mellitus (T2DM), is associated with notable global morbidity and mortality. Preventing the advancement of this condition by delaying the rate of glucose absorption through inhibition of α-amylase and α-glucosidase enzymatic activities is of utmost importance. Finding a safe antidiabetic drug is essential since those that are currently on the market have drawbacks like unpleasant side effects. The current study utilized computer-aided drug design (CADD), as a quick and affordable method to find a substitute drug template that can be used to control postprandial hyperglycemia by modulating the activity of α-amylase and α-glucosidase enzymes. The Natural Products Activity and Species database (NPASS) (30,926 compounds) was screened in silico, with a focus on evaluating drug-likeness, toxicity profiles and ability to bind on a target protein. Two molecules NPC204580 (Chrotacumine C) and NPC137813 (1-O-(2-Methoxy-4-Acetylphenyl)-6-O-(E-Cinnamoyl)-Beta-D-Glucopyranoside) were identified as potential dual inhibitors for α-amylase and α-glucosidase with free binding energies of -14.46 kcal/mol and -12.58 kcal/mol for α-amylase, and -8.42 kcal/mol and -8.76 kcal/mol for α-glucosidase, respectively. The molecules showed ionic, H-bonding and hydrophobic interactions with critical amino acid residues of both enzymes. Moreover, 100 ns molecular dynamic simulations showed that both molecules are stable on the receptors’ active sites based on root mean square deviation (RMSD), root mean square fluctuation (RMSF), and the Generalized Born surface area (GBSA) energy calculated. The two compounds are thus promising therapeutic agents for T2DM that merit further investigation due to their excellent binding energies, encouraging pharmacokinetics, toxicity profiles, and stability as demonstrated in simulated studies.
    URI
    https://doi.org/10.1371/journal.pone.0313758
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0313758
    http://ir-library.mmust.ac.ke:8080/xmlui/handle/123456789/3098
    Collections
    • Gold Collection [989]

    MMUST Library copyright © 2011-2022  MMUST Open Access Policy
    Contact Us | Send Feedback
     

     

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    MMUST Library copyright © 2011-2022  MMUST Open Access Policy
    Contact Us | Send Feedback